Every open market buy and sale of AbCellera Biologics Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are buying over the last 12 months: $3.5M bought and $0 sold.
Buying and selling by month
open market, last 12 monthsGet an alert when ABCL insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an ABCL officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
ABCL cluster buys
All ABCL cluster buys →- 2 insiders bought $796KTrades Nov 12, 2026 to Nov 13, 2026 · public Nov 13, 2026
- 3 insiders bought $1.5MTrades Aug 12, 2026 to Aug 24, 2026 · public Aug 14, 2026
- 2 insiders bought $857KTrades Feb 26, 2026 to Feb 27, 2026 · public Feb 27, 2026
A cluster buy is two or more insiders buying on the open market within 30 days of each other.
Every ABCL insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Nov 13, 2026 | Andrew BoothCFO | Buy | 8,600 | $11.33 | $97K | 491,400 | Nov 13Form 4 |
| Nov 12, 2026 | Thermopylae Holdings Ltd.10% owner | Buy | 60,565 | $11.54 | $699K | 56,194,662 | Nov 12Form 4 |
| Aug 24, 2026 | Michael R HaydenDirector | Buy | 53,613 | $10.64 | $570K | 1,373,397 | Aug 24Form 4 |
| Aug 18, 2026 | John S. MontalbanoDirector | Buy | 10,000 | $11.03 | $110K | 251,000 | Aug 18Form 4 |
| Aug 14, 2026 | Andrew BoothCFO | Buy | 37,200 | $10.32 | $384K | 482,800 | Aug 14Form 4 |
| Aug 12, 2026 | Michael R HaydenDirector | Buy | 46,387 | $10.37 | $481K | 1,319,784 | Aug 14Form 4 |
| May 14, 2026 | John S. MontalbanoDirector | Buy | 20,000 | $4.77 | $95K | 241,000 | May 18Form 4 |
| Feb 27, 2026 | Thermopylae Holdings Ltd.10% owner | Buy | 38,000 | $3.44 | $131K | 56,134,097 | Mar 2Form 4 |
| Feb 27, 2026 | Andrew BoothCFO | Buy | 42,600 | $3.42 | $146K | 195,600 | Feb 27Form 4 |
| Feb 26, 2026 | Thermopylae Holdings Ltd.10% owner | Buy | 177,457 | $3.27 | $580K | 56,096,097 | Feb 27Form 4 |
| Nov 26, 2025 | John S. MontalbanoDirector | Buy | 50,000 | $3.57 | $179K | 221,000 | Nov 26Form 4 |
| Mar 11, 2025 | Thermopylae Holdings Ltd.10% owner | Buy | 343,631 | $2.16 | $742K | 56,143,640 | Mar 11Form 4 |
| Mar 10, 2025 | John S. MontalbanoDirector | Buy | 25,000 | $2.30 | $58K | 171,000 | Mar 10Form 4 |
| Mar 6, 2025 | John S. MontalbanoDirector | Buy | 60,000 | $2.34 | $140K | 146,000 | Mar 7Form 4 |
ABCL insider trading FAQ
Are ABCL insiders buying or selling?
Insiders are buying over the last 12 months. 4 insiders bought $3.5M of ABCL on the open market in 11 trades, and 0 sold $0 in 0 trades.
When did an ABCL insider last buy shares?
Andrew Booth (CFO) bought 8,600 shares for $97K on Nov 13, 2026, reported on Nov 13, 2026.
When did an ABCL insider last sell shares?
There has been no open market insider sale of ABCL in the last two years.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
